A curated reading list of authoritative medical research, drug-safety databases, and focused analysis for researchers, patients, and advocates.
Long term outcome of Pigmentary Maculopathy after Elmiron: Key Facts & Context
In-depth context and analysis on this topic for researchers and advocates.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Centers for Disease Control and Prevention (CDC)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: ClinicalTrials.gov
Authoritative source for clinical, regulatory, and public-health background reading.